Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2 participants
INTERVENTIONAL
2014-03-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Testing Methods of Self-persuasion Involving Cigarette Smoking
NCT02069483
Mobile App Based Personalized Solutions and Tools for Medication Adherence of Rx Pills
NCT02072005
Smartphone Application for Smoking Cessation
NCT02134509
A Text-based Reduction Intervention for Smokeless Tobacco Cessation
NCT04315506
Addressing Tobacco Use Disparities Through an Innovative Mobile Phone Intervention
NCT02613689
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
48 hour smoking abstinence
Participants will maintain smoking abstinence for 48 hours
Smartphone
Participants will use an Android-based smartphone as their own for one month
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* between the ages of 18 and 65
* smoking of at least 10 cig/day of a brand delivering ≥ 0.5 mg nicotine (FTC method) for \> 1 year AND an afternoon expired CO concentration \>5 ppm (to confirm inhalation) or morning urinary cotinine \> 100 ng/mL
* willingness to carry and use a study smartphone as their own for one month
Exclusion Criteria
* use of smokeless tobacco products
* current use of nicotine replacement therapy or other smoking cessation treatment
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joseph McClernon, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke University Medical Center
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00044941
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.